Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan in Heart Failure With Hyponatremia (AQUATIC)
NCT02352285Phase 4Terminated
- Sponsor
- Otsuka Holdings
- Start
- Dec 2012
- Primary completion
- Jan 2017
- Countries
- 1
01
Overview
A Phase 4 trial of tolvaptan in hyponatremia, sponsored by Otsuka Holdings. Started Dec 2012; status: terminated.
02
Drugs
tolvaptan
03
Conditions
hyponatremia
Beyond the preview
Go deeper on NCT02352285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02352285.